Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Quantitative Diffusion and Fat Imaging of the Spine
Clinical trial update reporting on quantitative diffusion and fat imaging of the spine in osteoporosis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 [Phase 3]
Phase 3 trial IBCSG-1-98 evaluating bone density and bone loss in postmenopausal women with breast cancer receiving treatment has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 [Phase 3]
Phase 3 trial IBCSG-1-98 evaluating fingernail-based assessment of bone health in postmenopausal women with breast cancer on hormone therapy…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM) [Phase 3]
Phase 3 clinical trial update on sequential treatment for primary osteoporosis in postmenopausal women; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: A Randomized Controlled Trial of a Bone Density Decision Aide
This randomized controlled trial evaluated a bone density decision aid for osteoporosis. The study has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-07-12FDA Approved: CALCITONIN SALMON — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Calcitonin Salmon from Endo USA, Inc.
-
CLINICAL_TRIALS research · 2012-07-03Clinical Trial Update: Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density [NA]
This completed clinical trial investigates radiological, biological, genetic, and micro-architectural determinants of fractures in men with …
-
CLINICAL_TRIALS research · 2012-07-02Clinical Trial Update: Milk Supplementation and Energy Balance. [NA]
A completed clinical trial from Laval University evaluating milk supplementation and energy balance in obesity and osteoporosis.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Study of FORTEO Use in Subjects in the Community Setting
A completed study evaluating the use of FORTEO (teriparatide) in community-settings for osteoporosis, with results posted in 2012.
-
FDA approval · 2012-06-25FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for alendronate sodium supplied by Aurobindo Pharma Limited under ANDA090124.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Thai Traditional Massage Increases Biochemical Marker of Bone Formation in Postmenopausal Women
A completed clinical trial found that Thai traditional massage increased a biochemical marker of bone formation in postmenopausal women with…
-
EMA withdrawal · 2012-06-21EMA Lapsed: Fablyn (Lasofoxifene tartrate) — Dr. Friedrich Eberth Arzneimittel GmbH
EMA indicates the marketing authorization for Fablyn (lasofoxifene tartrate) has lapsed, primarily in the osteoporosis/postmenopausal settin…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan [Phase 3]
Ono Pharmaceutical's ONO-5920 completed a Phase 3 controlled trial in patients with involutional osteoporosis in Japan.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis [Phase 2]
This update notes the completion of a Phase 2, controlled study of ONO-5334 in postmenopausal women with osteopenia or osteoporosis.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Beneficial Effects of Long Term Menaquinone-7 [NA]
Completed trial reporting beneficial effects of long-term menaquinone-7 on bone loss (osteoporosis) and arteriosclerosis.
-
FDA label_change · 2012-06-07FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approves Amgen's supplemental application for PROLIA (denosumab) to modify the product labeling. The action pertains to updating the lab…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer [NA]
This completed clinical trial compared adding raloxifene to an exercise program versus exercise alone in women previously treated for breast…
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study of Low-Magnitude, High-Frequency Vibration Treatment on Osteoporotic Hip Fracture Healing [Phase 2, Phase 3]
Clinical trial update for low-magnitude, high-frequency vibration treatment aimed at osteoporotic hip fracture healing in Phase 2/Phase 3, w…
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass [Phase 2]
Phase 2 clinical trial evaluating intranasal teriparatide on the bone formation biomarker P1NP in postmenopausal women with low bone mass. T…
-
FDA approval · 2012-05-22FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC, indicating updated labeling or a…
-
FDA label_change · 2012-05-17FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for alendronate sodium by Aurobindo Pharma Limited, indicating a modification to an already approved…
-
FDA approval · 2012-05-16FDA Approved: ALENDRONATE — Supplemental Application (Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ALENDRONATE SODIUM tablets from Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., enabling a …
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Evaluating Ways to Improve Medication Use Among People With Osteoporosis [Phase 3]
Phase 3 clinical trial update evaluating strategies to improve medication use among people with osteoporosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis [Phase 2]
Phase 2 trial update reporting safety and efficacy data for AAE581 in postmenopausal women with osteoporosis. The study is sponsored by Nova…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES) [Phase 4]
A Phase 4 study (STEP) evaluating imaging techniques ImaTx and DXA in postmenopausal women with primary osteoporosis using Preotact has comp…